Literature DB >> 18583976

Conflicting evidence on the frequency of ESR1 amplification in breast cancer.

Donna G Albertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18583976     DOI： 10.1038/ng0708-821

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  12 in total

1.  Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis.

Authors:  Evangelos Tsiambas; Stavros N Georgiannos; Nikolaos Salemis; Despoina Alexopoulou; Sofia Lambropoulou; Blerta Dimo; Ioannis Ioannidis; Christos Kravvaritis; Andreas Karameris; Efstratios Patsouris; Spyridon Dourakis
Journal:  Med Oncol       Date:  2010-05-11       Impact factor: 3.064

2.  Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.

Authors:  Ahmed Basudan; Nolan Priedigkeit; Ryan J Hartmaier; Ethan S Sokol; Amir Bahreini; Rebecca J Watters; Michelle M Boisen; Rohit Bhargava; Kurt R Weiss; Maria M Karsten; Carsten Denkert; Jens-Uwe Blohmer; Jose P Leone; Ronald L Hamilton; Adam M Brufsky; Esther Elishaev; Peter C Lucas; Adrian V Lee; Steffi Oesterreich
Journal:  Mol Cancer Res       Date:  2018-10-24       Impact factor: 5.852

3.  ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.

Authors:  Anne-Vibeke Laenkholm; Ann Knoop; Bent Ejlertsen; Tine Rudbeck; Maj-Britt Jensen; Sven Müller; Anne Elisabeth Lykkesfeldt; Birgitte Bruun Rasmussen; Kirsten Vang Nielsen
Journal:  Mol Oncol       Date:  2012-05-08       Impact factor: 6.603

4.  Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Authors:  B Ejlertsen; J Aldridge; K V Nielsen; M M Regan; K L Henriksen; A E Lykkesfeldt; S Müller; R D Gelber; K N Price; B B Rasmussen; G Viale; H Mouridsen
Journal:  Ann Oncol       Date:  2011-10-10       Impact factor: 32.976

Review 5.  Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Authors:  Frederik Holst
Journal:  World J Clin Oncol       Date:  2016-04-10

Review 6.  Current research topics in endocrine therapy for breast cancer.

Authors:  Hiroko Yamashita
Journal:  Int J Clin Oncol       Date:  2008-10-23       Impact factor: 3.402

7.  Androgen receptor as a targeted therapy for breast cancer.

Authors:  Joseph P Garay; Ben H Park
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

8.  The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.

Authors:  Joseph P Garay; Bedri Karakas; Abde M Abukhdeir; David P Cosgrove; John P Gustin; Michaela J Higgins; Hiroyuki Konishi; Yuko Konishi; Josh Lauring; Morassa Mohseni; Grace M Wang; Danijela Jelovac; Ashani Weeraratna; Cheryl A Sherman Baust; Patrice J Morin; Antoun Toubaji; Alan Meeker; Angelo M De Marzo; Gloria Lewis; Andrea Subhawong; Pedram Argani; Ben H Park
Journal:  Breast Cancer Res       Date:  2012-02-09       Impact factor: 6.466

9.  Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification.

Authors:  Robert Kornegoor; Cathy B Moelans; Anoek H J Verschuur-Maes; Marieke C H Hogenes; Peter C de Bruin; Joost J Oudejans; Luigi Marchionni; Paul J van Diest
Journal:  Breast Cancer Res Treat       Date:  2012-04-13       Impact factor: 4.872

10.  ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.

Authors:  Cathy B Moelans; Hanneke N Monsuur; Johannes H de Pinth; Remco D Radersma; Roel A de Weger; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2011-05-04       Impact factor: 6.730
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.